You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage II non-small cell lung cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-Squamous Non-Small Cell Lung Carcinoma, Stage I NSCLC, Stage IA Non-Small Cell Lung Carcinoma Trial in Abington,

Active, not recruiting
  • Non-Squamous Non-Small Cell Lung Carcinoma
  • +7 more
  • Nivolumab
  • +3 more
  • Abington, Pennsylvania
  • +1 more
Sep 14, 2022

Resectable Stage II-IIIB Driver Gene-negative Non-small Cell

Not yet recruiting
  • NSCLC
    • Changsha, Hunan, China
      Hunan Cancer Hospital
    Aug 6, 2023

    NSCLC Trial in Shanghai (SH-1028 tablets, Placebo SH-1028 tablets)

    Recruiting
    • Non-small Cell Lung Cancer
    • SH-1028 tablets
    • Placebo SH-1028 tablets
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Oct 6, 2023

    Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III Trial in Tampa (Genomically

    Recruiting
    • Nonsmall Cell Lung Cancer
    • +3 more
    • Genomically Guided Radiation Therapy (RT)
    • Tampa, Florida
      Moffitt Cancer Center
    May 23, 2023

    Stage II-IIIB(N2) NSCLC Trial in Shanghai (TQB2450, Carboplatin, Pemetrexed)

    Not yet recruiting
    • Stage II-IIIB(N2) Non-small Cell Lung Cancer
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Oct 26, 2023

    Stage I NSCLC AJCC v7, Stage IA Non-Small Cell Lung Carcinoma AJCC v7, Stage IB Non-Small Cell Lung Carcinoma AJCC v7 Trial in

    Recruiting
    • Stage I Non-Small Cell Lung Cancer AJCC v7
    • +6 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    May 2, 2022

    NSCLC Trial in Shanghai (SBRT+LDRT, Toripalimab, Chemotherapy drug)

    Recruiting
    • NSCLC
    • SBRT+LDRT
    • +2 more
    • Shanghai, Shanghai, China
      Shanghai Chest Hospital
    Apr 2, 2023

    NSCLC Trial (V940, Pembrolizumab, Placebo)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • V940
    • +2 more
    • (no location specified)
    Oct 5, 2023

    Stage I Lung Cancer, Stage I NSCLC AJCC v7, Stage IA Non-Small Cell Lung Carcinoma AJCC v7 Trial in Atlanta (drug, procedure,

    Active, not recruiting
    • Stage I Lung Cancer
    • +7 more
    • Fludeoxyglucose F-18
    • +2 more
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    Mar 2, 2022

    Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage III Lung Cancer AJCC v8 Trial in Rochester (Best Practice,

    Not yet recruiting
    • Lung Non-Small Cell Carcinoma
    • +3 more
    • Best Practice
    • +4 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Nov 14, 2023

    Unresectable Lung Non-Small Cell Carcinoma Trial (serplulimab plus chemo as conversion treatment)

    Not yet recruiting
    • Unresectable Lung Non-Small Cell Carcinoma
    • serplulimab plus chemotherapy as conversion treatment
    • (no location specified)
    Apr 27, 2023

    Lung Cancer, Nonsmall Cell, Lung Cancer Stage III Trial (combination product, drug, procedure, radiation)

    Not yet recruiting
    • Lung Cancer, Nonsmall Cell
    • Lung Cancer Stage III
    • Nivolumab and Chemotherapy
    • +3 more
    • (no location specified)
    Aug 15, 2023

    Non Squamous Non Small Cell Lung Cancer, EGFR Positive NSCLC Trial (Toripalimab plus Chemotherapy)

    Not yet recruiting
    • Non Squamous Non Small Cell Lung Cancer
    • EGFR Positive Non-small Cell Lung Cancer
    • Toripalimab plus Chemotherapy
    • (no location specified)
    Jul 28, 2023

    Stage I Lung Non-Small Cell Cancer AJCC v7, Stage IA Lung Non-Small Cell Carcinoma AJCC v7, Stage IB Lung Non-Small Cell

    Active, not recruiting
    • Stage I Lung Non-Small Cell Cancer AJCC v7
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 24, 2022

    NSCLC Trial in Shanghai (Carbon ion beam radiotherapy)

    Recruiting
    • Non-small Cell Lung Cancer
    • Carbon ion beam radiotherapy
    • Shanghai, Shanghai, China
      Shanghai Proton and Heavy Ion Center
    Nov 10, 2022

    Mesothelin Positive, Stage III NSCLC AJCC v7, Stage IIIA NSCLC AJCC v7 Trial in Phoenix, Jacksonville, Rochester (Anetumab

    Terminated
    Has Results
    • Mesothelin Positive
    • +4 more
    • Anetumab Ravtansine
    • +2 more
    • Phoenix, Arizona
    • +2 more
    Jan 5, 2023

    Locally Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Trial in

    Recruiting
    • Locally Advanced Lung Non-Small Cell Carcinoma
    • +12 more
    • Computed Tomography
    • Contrast Agent
    • New Brunswick, New Jersey
    • +1 more
    Nov 2, 2022

    Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIA Lung Cancer AJCC v8 Trial in Los Angeles (Atezolizumab

    Recruiting
    • Lung Non-Small Cell Carcinoma
    • +10 more
    • Atezolizumab and Recombinant Human Hyaluronidase
    • Survey Administration
    • Los Angeles, California
      USC / Norris Comprehensive Cancer Center
    Jan 31, 2023

    Non-squamous Non-small-cell Lung Cancer, Stage IV NSCLC, ROS1 Gene Rearrangement Trial in Toronto (Crizotinib)

    Recruiting
    • Non-squamous Non-small-cell Lung Cancer
    • +4 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Jan 8, 2023

    Aspirin in Combination With Trametinib and Dabrafenib

    Not yet recruiting
    • NSCLC
    • +4 more
    • Combind asprin with Trametinib and Dabrafenib
    • (no location specified)
    Aug 4, 2023

    Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, biological, drug)

    Not yet recruiting
    • Recurrent Lung Non-Small Cell Carcinoma
    • Stage IV Lung Cancer AJCC v8
    • Biospecimen Collection
    • +5 more
    • (no location specified)
    Sep 7, 2023

    Non Small Cell Lung Cancer Trial (Tislelizumab, Ociperlimab, LBL-007)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • (no location specified)
    Jan 30, 2023

    Unresectable Non-Small Cell Lung Cancer (Stage III) in Canada

    Completed
    • Non-small Cell Lung Cancer
    • Calgary, Alberta, Canada
    • +4 more
    Jun 28, 2023

    Lung Non-Small Cell Carcinoma Trial (Amivantamab, Biospecimen Collection, Computed Tomography)

    Not yet recruiting
    • Lung Non-Small Cell Carcinoma
    • Amivantamab
    • +3 more
    • (no location specified)
    Oct 30, 2023

    NSCLC, Stage II-IIIA, Immunotherapy Trial in Shanghai (Serplulimab and Chemotherapy)

    Recruiting
    • Non-small Cell Lung Cancer
    • +3 more
    • Serplulimab and Chemotherapy
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Mar 27, 2023